Literature DB >> 22872113

Can nonrandomized studies on the safety of antidepressants during pregnancy convincingly beat confounding, chance, and prior beliefs?

Kristin Palmsten1, Sonia Hernández-Díaz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22872113      PMCID： PMC4133936          DOI： 10.1097/EDE.0b013e318258fbb2

Source DB:  PubMed          Journal:  Epidemiology        ISSN： 1044-3983            Impact factor:   4.822


× No keyword cloud information.
  10 in total

1.  Clinical practice. Depression during pregnancy.

Authors:  Donna E Stewart
Journal:  N Engl J Med       Date:  2011-10-27       Impact factor: 91.245

2.  Reporting birth defects surveillance data 1968-2003.

Authors:  Adolfo Correa; Janet D Cragan; James E Kucik; Clinton J Alverson; Suzanne M Gilboa; Renu Balakrishnan; Matthew J Strickland; C Wes Duke; Leslie A O'Leary; Tiffany Riehle-Colarusso; Csaba Siffel; Don Gambrell; Debra Thompson; Michael Atkinson; Jamuna Chitra
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2007-02

3.  Increasing use of antidepressants in pregnancy.

Authors:  William O Cooper; Mary E Willy; Stephen J Pont; Wayne A Ray
Journal:  Am J Obstet Gynecol       Date:  2007-06       Impact factor: 8.661

4.  Pregnancy outcome after exposure to antidepressants and the role of maternal depression: results from the Norwegian Mother and Child Cohort Study.

Authors:  Hedvig Nordeng; Marleen M H J van Gelder; Olav Spigset; Gideon Koren; Adrienne Einarson; Malin Eberhard-Gran
Journal:  J Clin Psychopharmacol       Date:  2012-04       Impact factor: 3.153

5.  Depression and serotonin reuptake inhibitor treatment as risk factors for preterm birth.

Authors:  Kimberly A Yonkers; Errol R Norwitz; Megan V Smith; Charles J Lockwood; Nathan Gotman; Edward Luchansky; Haiqun Lin; Kathleen Belanger
Journal:  Epidemiology       Date:  2012-09       Impact factor: 4.822

6.  Does antidepressant use attenuate the risk of a major depressive episode in pregnancy?

Authors:  Kimberly A Yonkers; Nathan Gotman; Megan V Smith; Ariadna Forray; Kathleen Belanger; Wendy L Brunetto; Haiqun Lin; Ronald T Burkman; Carolyn M Zelop; Charles J Lockwood
Journal:  Epidemiology       Date:  2011-11       Impact factor: 4.822

7.  Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment.

Authors:  Lee S Cohen; Lori L Altshuler; Bernard L Harlow; Ruta Nonacs; D Jeffrey Newport; Adele C Viguera; Rita Suri; Vivien K Burt; Victoria Hendrick; Alison M Reminick; Ada Loughead; Allison F Vitonis; Zachary N Stowe
Journal:  JAMA       Date:  2006-02-01       Impact factor: 56.272

Review 8.  The preterm birth syndrome: a prototype phenotypic classification.

Authors:  Jose Villar; Aris T Papageorghiou; Hannah E Knight; Michael G Gravett; Jay Iams; Sarah A Waller; Michael Kramer; Jennifer F Culhane; Fernando C Barros; Agustín Conde-Agudelo; Zulfiqar A Bhutta; Robert L Goldenberg
Journal:  Am J Obstet Gynecol       Date:  2011-10-25       Impact factor: 8.661

9.  First trimester paroxetine use and the prevalence of congenital, specifically cardiac, defects: a meta-analysis of epidemiological studies.

Authors:  Keele E Wurst; Charles Poole; Sara A Ephross; Andrew F Olshan
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2010-03

10.  Use of antidepressant medications during pregnancy: a multisite study.

Authors:  Susan E Andrade; Marsha A Raebel; Jeffrey Brown; Kimberly Lane; James Livingston; Denise Boudreau; Sharon J Rolnick; Douglas Roblin; David H Smith; Mary E Willy; Judy A Staffa; Richard Platt
Journal:  Am J Obstet Gynecol       Date:  2007-10-01       Impact factor: 8.661
  10 in total
  12 in total

1.  Methodological considerations in assessing the effectiveness of antidepressant medication continuation during pregnancy using administrative data.

Authors:  Sonja A Swanson; Sonia Hernandez-Diaz; Kristin Palmsten; Helen Mogun; Mark Olfson; Krista F Huybrechts
Journal:  Pharmacoepidemiol Drug Saf       Date:  2015-06-04       Impact factor: 2.890

2.  The Roles of Maternal Depression, Serotonin Reuptake Inhibitor Treatment, and Concomitant Benzodiazepine Use on Infant Neurobehavioral Functioning Over the First Postnatal Month.

Authors:  Amy L Salisbury; Kevin E O'Grady; Cynthia L Battle; Katherine L Wisner; George M Anderson; Laura R Stroud; Cynthia L Miller-Loncar; Marion E Young; Barry M Lester
Journal:  Am J Psychiatry       Date:  2015-10-30       Impact factor: 18.112

3.  Impact of prenatal exposure to serotonin reuptake inhibitors or maternal major depressive disorder on infant developmental outcomes.

Authors:  Aimee K Santucci; Lynn T Singer; Stephen R Wisniewski; James F Luther; Heather F Eng; John L Dills; Dorothy K Y Sit; Barbara H Hanusa; Katherine L Wisner
Journal:  J Clin Psychiatry       Date:  2014-10       Impact factor: 4.384

4.  Impact of antidepressant treatment during pregnancy on obstetric outcomes among women previously treated for depression: an observational cohort study.

Authors:  K K Venkatesh; V M Castro; R H Perlis; A J Kaimal
Journal:  J Perinatol       Date:  2017-07-06       Impact factor: 2.521

5.  Associations of Maternal Antidepressant Use During the First Trimester of Pregnancy With Preterm Birth, Small for Gestational Age, Autism Spectrum Disorder, and Attention-Deficit/Hyperactivity Disorder in Offspring.

Authors:  Ayesha C Sujan; Martin E Rickert; A Sara Öberg; Patrick D Quinn; Sonia Hernández-Díaz; Catarina Almqvist; Paul Lichtenstein; Henrik Larsson; Brian M D'Onofrio
Journal:  JAMA       Date:  2017-04-18       Impact factor: 56.272

6.  Antidepressant use during pregnancy and risk of adverse neonatal outcomes: A comprehensive investigation of previously identified associations.

Authors:  Anna-Sophie Rommel; Natalie C Momen; Nina Maren Molenaar; Esben Agerbo; Veerle Bergink; Trine Munk-Olsen; Xiaoqin Liu
Journal:  Acta Psychiatr Scand       Date:  2022-02-18       Impact factor: 7.734

7.  Patterns of prenatal antidepressant exposure and risk of preeclampsia and postpartum haemorrhage.

Authors:  Kristin Palmsten; Christina D Chambers; Alan Wells; Gretchen Bandoli
Journal:  Paediatr Perinat Epidemiol       Date:  2020-03-24       Impact factor: 3.980

8.  Neonatal Discontinuation Syndrome in Serotonergic Antidepressant-Exposed Neonates.

Authors:  Amy Yang; Jody D Ciolino; Emily Pinheiro; Laura J Rasmussen-Torvik; Dorothy K Y Sit; Katherine L Wisner
Journal:  J Clin Psychiatry       Date:  2017-05       Impact factor: 4.384

9.  Firearm access and adolescent suicide risk: toward a clearer understanding of effect size.

Authors:  Sonja A Swanson; Mara Eyllon; Yi-Han Sheu; Matthew Miller
Journal:  Inj Prev       Date:  2020-05-14       Impact factor: 2.399

10.  Long-term prenatal effects of antidepressant use on the risk of affective disorders in the offspring: a register-based cohort study.

Authors:  Anna-Sophie Rommel; Natalie C Momen; Nina Maren Molenaar; Xiaoqin Liu; Trine Munk-Olsen; Veerle Bergink
Journal:  Neuropsychopharmacology       Date:  2021-04-05       Impact factor: 8.294
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.